Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Hepatitis C virus-human immunodeficiency virus coinfection
Mark S. Sulkowski
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatitis C virus-human immunodeficiency virus coinfection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Coinfection
100%
Hepacivirus
95%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
80%
telaprevir
77%
HIV
71%
Ribavirin
58%
Drug-Related Side Effects and Adverse Reactions
47%
Hepatitis C virus NS3-4A serine protease
47%
Chronic Hepatitis C
26%
Protease Inhibitors
26%
Sexual and Gender Minorities
26%
Drug Interactions
25%
Infections
24%
HIV Infections
22%
Liver Diseases
21%
Pharmaceutical Preparations
21%
Therapeutics
16%
Morbidity
15%
Injections
14%
Mortality
12%
Population
10%